Leprosy in the 21st century

Area of Science:

• Medical Microbiology
• Genetics
• Public Health

Background:

• Multidrug therapy (MDT) has been available for over 30 years, significantly improving leprosy (Hansen's disease) treatment and patient outlook.
• Despite MDT, global incidence of leprosy remains high, with patients frequently experiencing long-term complications.
• Leprosy reactions, inflammatory episodes causing significant disability, continue to pose treatment challenges even after MDT completion.

Purpose of the Study:

• To review recent advancements in understanding leprosy (Hansen's disease) genetics, susceptibility, and disease reservoirs.
• To discuss the implications of these findings for Hansen's disease control strategies and patient health outcomes.
• To highlight contemporary challenges in managing leprosy, including treatment of reactions and issues related to patient migration.

Main Methods:

• Review of recent scientific literature on leprosy (Hansen's disease).
• Analysis of genetic, epidemiological, and clinical findings.
• Discussion of implications for public health and patient care.

Main Results:

• Recent research provides new insights into genetic factors influencing leprosy susceptibility.
• Understanding disease reservoirs is evolving, offering potential new control avenues.
• Leprosy reactions remain a significant challenge, contributing to long-term patient disability.

Conclusions:

• Continued research into leprosy (Hansen's disease) genetics, susceptibility, and reservoirs is essential for improving control measures.
• Addressing challenges like leprosy reactions and patient migration is critical for enhancing patient outcomes.
• Future research should focus on integrating genetic insights and reservoir data for more effective Hansen's disease management.